Tarsus Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Tarsus Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q3 2024.
  • Tarsus Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -39.3 %, a 18.2% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. annual Return On Assets for 2023 was -58.2 %, a 111% decline from 2022.
  • Tarsus Pharmaceuticals, Inc. annual Return On Assets for 2022 was -27.6 %, a 283% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -39.3 +8.73 +18.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -47.6 -5.56 -13.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -55.3 -27.2 -96.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -58.2 -30.6 -111% Oct 1, 2023 Dec 31, 2023
Q3 2023 -48 -18.2 -61% Jul 1, 2023 Sep 30, 2023
Q2 2023 -42.1 -14 -49.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -28.1 -4.56 -19.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -27.6 -20.4 -283% Oct 1, 2022 Dec 31, 2022
Q3 2022 -29.8 -24.3 -442% Jul 1, 2022 Sep 30, 2022
Q2 2022 -28.1 -25.2 -853% Apr 1, 2022 Jun 30, 2022
Q1 2022 -23.6 Jan 1, 2022 Mar 31, 2022
Q4 2021 -7.21 Oct 1, 2021 Dec 31, 2021
Q3 2021 -5.5 Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.95 Apr 1, 2021 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.